Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons

Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons

Background: Drug-coated balloons (DCBs), which deliver anti-proliferative drugs with the aid of excipients, have emerged as a new endovascular therapy for the treatment of peripheral arterial disease. In this study, we evaluated the use of keratose (KOS) as a novel DCB-coating excipient to deliver a...

Full description

Bibliographic Details
Main Authors:	Emily Goel, Megan Erwin, Claire V. Cawthon, Carson Schaff, Nathaniel Fedor, Trevor Rayl, Onree Wilson, Uwe Christians, Thomas C. Register, Randolph L. Geary, Justin Saul, Saami K. Yazdani
Format:	Article
Language:	English
Published:	MDPI AG 2020-03-01
Series:	Molecules
Subjects:	Keratose drug-coated balloon paclitaxel drug delivery pre-clinical peripheral arterial disease
Online Access:	https://www.mdpi.com/1420-3049/25/7/1596

Similar Items

In vitro and in vivo Assessment of Keratose as a Novel Excipient of Paclitaxel Coated Balloons
by: Emily Turner, et al.
Published: (2018-07-01)

Inflammation of Actinic Keratoses Induced by Combination of Carboplatin and Paclitaxel: Two Case Reports
by: Špela Šuler Baglama, et al.
Published: (2022-12-01)

Kératoses séborrhéiques: une localisation inhabituelle
by: Hasnaa Zaouri, et al.
Published: (2017-05-01)

A case of vasculitis after paclitaxel drug-coated balloon angioplasty
by: Kelly Hawkins, BS, et al.
Published: (2022-05-01)

Angioplasty of Dysfunctional Dialysis Fistula or Graft with Resveratrol-Excipient and Paclitaxel-Coated Balloon Improves Primary Patency Rates Compared to Plain Angioplasty Alone
by: Matej Novak, et al.
Published: (2022-12-01)

Arsenical keratoses: Case report from nonendemic area of Amritsar
by: Tejinder Kaur, et al.
Published: (2021-01-01)

Cutaneous polyarteritis nodosa resulting from a paclitaxel-eluting balloon angioplasty
by: Allison Montgomery, BA, et al.
Published: (2018-01-01)

Inflamed actinic keratoses as a biomarker in repositioning of chemotherapeutics: a systematic review and meta-analysis
by: Špela Šuler Baglama, et al.
Published: (2022-11-01)

Acute drug transfer and particle release of drug coated balloons within a porcine in-vitro model
by: Brandt-Wunderlich Christoph, et al.
Published: (2017-09-01)

Preparation and Characterization of Water Hyacinth Cellulose/ Keratose Composite Films
by: Patcharida Chaosri, et al.
Published: (2020-12-01)

Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
by: Konstantinos Katsanos, et al.
Published: (2018-12-01)

The Paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: An angiographic follow up study
by: Upendra Kaul, et al.
Published: (2013-09-01)

AKASI and Near-Infrared Spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients
by: Federica Veronese, et al.
Published: (2022-09-01)

A New Frontier for Drug-Coated Balloons: Treatment of “De Novo” Stenosis in Large Vessel Coronary Artery Disease
by: Alessandro Sciahbasi, et al.
Published: (2024-02-01)

Drug Coated Balloon in the Treatment of De Novo Coronary Artery Disease: A Narrative Review
by: Filippo Zilio, et al.
Published: (2023-05-01)

Eruptive Seborrheic Keratoses Restricted to Plaque/Patch-Stage Mycosis Fungoides
by: Eve Lebas, et al.
Published: (2017-06-01)

Technical success, clinical efficacy, and insight into the causes of restenosis after the percutaneous coronary intervention of de novo coronary artery lesions using a paclitaxel-coated balloon with citrate ester excipient
by: Jerry Tervo, et al.
Published: (2022-10-01)

Malignant transformation of actinic keratoses to squamous cell carcinoma in an albino
by: Ramalingam Vijaya, et al.
Published: (2009-01-01)

Combination-Based Strategies for the Treatment of Actinic Keratoses with Photodynamic Therapy: An Evidence-Based Review
by: Stefano Piaserico, et al.
Published: (2022-08-01)

Patient assessment of 5-fluorouracil and imiquimod for the treatment of actinic keratoses: a retrospective study of real-world effectiveness
by: Veronica K. Emmerich, et al.
Published: (2022-05-01)

Efficacy and safety of drug-coated balloons according to coronary vessel size. A report from the BASKET-SMALL 2 trial
by: Ahmed Farah, et al.
Published: (2022-08-01)

Is Paclitaxel Causing Mortality During Lower‐Extremity Revascularization?
by: Rajesh V. Swaminathan, et al.
Published: (2019-05-01)

Treatment of coronary lesions with a novel crystalline sirolimus-coated balloon
by: Mehdi Madanchi, et al.
Published: (2024-02-01)

Development of keratin nanoparticles for controlled gastric mucoadhesion and drug release
by: Zhongjun Cheng, et al.
Published: (2018-03-01)

Drug-Coated Balloons: Drugs Beyond Paclitaxel?
by: Tobias Haase, et al.
Published: (2022-10-01)

The appearance of eruptive seborrheic keratoses over linear verrucous epidermal nevus − A report
by: Poovanur Sadasivam Subramaniam Ranugha, et al.
Published: (2018-01-01)

One-Year Outcomes of the ROBUST II Study Evaluating the Use of a Drug-Coated Balloon for Treatment of Urethral Stricture
by: Jessica M. DeLong, et al.
Published: (2022-01-01)

A pilot study of a novel paclitaxel-coated angioplasty catheter for lower extremity peripheral artery disease: a pilot study
by: Serpil Şahin, et al.
Published: (2023-04-01)

Minimal invasive treatment of urethral strictures: An experimental study of the effect of Paclitaxel coated balloons in the wall of strictured rabbit’s urethra
by: Konstantinos Pagonis, et al.
Published: (2024-02-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
by: Guillaume Marquis-Gravel, et al.
Published: (2017-09-01)

Research progress of drug eluting balloon in arterial circulatory system
by: Keji Lu, et al.
Published: (2024-03-01)

Paclitaxel-Coated versus Uncoated Balloon for Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis
by: Qiwei Li, et al.
Published: (2022-09-01)

Coronary artery aneurysm formation after paclitaxel-coated balloon-only intervention for de novo coronary chronic total occlusion
by: Eun Jung Jun, et al.
Published: (2023-01-01)

Pre-Clinical Investigation of Liquid Paclitaxel for Local Drug Delivery: A Pilot Study
by: Claire V. Cawthon, et al.
Published: (2020-11-01)

Infantile anogenital digitate keratoses: A case series of a novel entity
by: Efrat Bar-Ilan, MD, et al.
Published: (2023-02-01)

In Vivo Non-Invasive Evaluation of Actinic Keratoses Response to Methyl-Aminolevulinate-Photodynamic Therapy (MAL-PDT) by Reflectance Confocal Microscopy
by: Marina Venturini, et al.
Published: (2014-03-01)

Short and long terms clinical outcomes of Paclitaxel drug-eluting balloons applied for de-novo coronary artery lesions in the context of acute coronary syndrome: A real world experience
by: Ahmed Ayuna, et al.
Published: (2021-05-01)

ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial
by: Ilka Ott, et al.
Published: (2017-07-01)

Design and use of an ex vivo peripheral simulating bioreactor system for pharmacokinetic analysis of a drug coated stent
by: Danyi Chen, et al.
Published: (2024-03-01)

Propensity score-matched analysis of six-month outcomes of paclitaxel-coated balloons combined with UltraScore balloons versus conventional scoring balloons for femoropopliteal lesions
by: Takuya Haraguchi, et al.
Published: (2023-05-01)